Tag Archives: More

Moderna Plans Three More mRNA Vaccines, Not All for Infection

Moderna produces one of three COVID shots available in the U.S.1 In November 2021, Moderna released data on third-quarter sales showing phenomenal profits from the vaccine of $ 5 billion worldwide and forecasted $ 18 billion for the year just from the mRNA vaccine.2 To take advantage of this revenue stream, the company announced they… Read More »

The Latest: Maine CDC: Rural areas need more COVID testing

PORTLAND, Maine — Maine’s rural areas need better access to COVID-19 testing, the head of the state’s Center for Disease Control and Prevention said. The percent positivity rate in some of Maine’s rural counties is much higher than it is in more densely populated areas such as Cumberland County. Federal data show the percent positivity… Read More »

Walmart signals plans to offer telehealth in 16 more states

The medical group for Walmart Health has filed paperwork to do business in more than a dozen more states – and a spokesperson told Insider that the moves are not related to physical clinics.   Instead, the preparation regards the retail giant’s pending acquisition of telehealth vendor MeMD earlier this year.   “We’ve expressed our… Read More »

“Heroes Work Here:” Never More True at Angel Medical Center Than During the Pandemic Year

Karen Gorby By Karen S. Gorby, RN, MSN, MBA, CENP, FACHE It’s May, and as we enjoy a beautiful spring — as well as the chance to get out and about more since we have been fortunate to have access to the COVID-19 vaccine — it promises to be quite different than last year’s. Twelve… Read More »

ASCO: Exelixis releases more details on Cabometyx thyroid cancer data that wooed Ipsen

When Ipsen announced last week that it wanted in on Exelixis’ Cabometyx for thyroid cancer, the company pegged that move to the oncology drug’s promising late-stage trial results. Now, Exelixis is offering up more details of that very trial. For a phase 3 study up for presentation at the virtual American Society of Clinical Oncology meeting, investigators… Read More »